JP2022546594A5 - - Google Patents

Info

Publication number
JP2022546594A5
JP2022546594A5 JP2022514704A JP2022514704A JP2022546594A5 JP 2022546594 A5 JP2022546594 A5 JP 2022546594A5 JP 2022514704 A JP2022514704 A JP 2022514704A JP 2022514704 A JP2022514704 A JP 2022514704A JP 2022546594 A5 JP2022546594 A5 JP 2022546594A5
Authority
JP
Japan
Prior art keywords
sequence
nucleic acid
crispr
target nucleic
related protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022514704A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022546594A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/049534 external-priority patent/WO2021046442A1/en
Publication of JP2022546594A publication Critical patent/JP2022546594A/ja
Publication of JP2022546594A5 publication Critical patent/JP2022546594A5/ja
Pending legal-status Critical Current

Links

JP2022514704A 2019-09-05 2020-09-04 新規crispr dnaターゲティング酵素及びシステム Pending JP2022546594A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962896308P 2019-09-05 2019-09-05
US62/896,308 2019-09-05
PCT/US2020/049534 WO2021046442A1 (en) 2019-09-05 2020-09-04 Novel crispr dna targeting enzymes and systems

Publications (2)

Publication Number Publication Date
JP2022546594A JP2022546594A (ja) 2022-11-04
JP2022546594A5 true JP2022546594A5 (enExample) 2023-09-11

Family

ID=74852250

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022514704A Pending JP2022546594A (ja) 2019-09-05 2020-09-04 新規crispr dnaターゲティング酵素及びシステム

Country Status (7)

Country Link
US (1) US20220282283A1 (enExample)
EP (1) EP4025588A4 (enExample)
JP (1) JP2022546594A (enExample)
CN (1) CN114341166A (enExample)
AU (1) AU2020341711A1 (enExample)
CA (1) CA3153005A1 (enExample)
WO (1) WO2021046442A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022284804A1 (en) 2021-06-01 2023-12-07 Arbor Biotechnologies, Inc. Gene editing systems comprising a crispr nuclease and uses thereof
US12131057B2 (en) * 2022-01-28 2024-10-29 Western Digital Technologies, Inc. Encoding and integrity markers for molecular storage applications
CA3252595A1 (en) 2022-05-25 2023-11-30 Metagenomi Therapeutics, Inc. LIVER ENZYME EXPRESSION SUPPLEMENTATION
US20260232844A1 (en) 2023-02-15 2026-08-13 Arbor Biotechnologies, Inc. Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript
CN121127588A (zh) * 2023-03-08 2025-12-12 宏基因组学公司 2类v型crispr系统
WO2025107617A1 (zh) * 2023-11-24 2025-05-30 华智生物技术有限公司 CRISPR/Cas效应蛋白及系统
WO2025171210A1 (en) 2024-02-09 2025-08-14 Arbor Biotechnologies, Inc. Compositions and methods for gene editing via homology-mediated end joining
WO2026015829A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Small reverse transcriptases and gene editing systems comprising such
WO2026015832A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Reverse transcriptases and gene editing systems comprising such

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3012631A1 (en) * 2015-06-18 2016-12-22 The Broad Institute Inc. Novel crispr enzymes and systems
US9790490B2 (en) * 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
WO2016205759A1 (en) * 2015-06-18 2016-12-22 The Broad Institute Inc. Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
CN116814590A (zh) * 2015-10-22 2023-09-29 布罗德研究所有限公司 Vi-b型crispr酶和系统
WO2017070632A2 (en) * 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
WO2017184789A1 (en) * 2016-04-19 2017-10-26 Keto Patent Group, Inc. Administration of berberine metabolites
US11352647B2 (en) * 2016-08-17 2022-06-07 The Broad Institute, Inc. Crispr enzymes and systems
US10392616B2 (en) * 2017-06-30 2019-08-27 Arbor Biotechnologies, Inc. CRISPR RNA targeting enzymes and systems and uses thereof
WO2019051419A1 (en) * 2017-09-08 2019-03-14 University Of North Texas Health Science Center Engineered cas9 variants
EP3983536A4 (en) * 2019-06-14 2023-11-29 Arbor Biotechnologies, Inc. NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS

Similar Documents

Publication Publication Date Title
JP2022547524A5 (enExample)
JP2022546701A5 (enExample)
JP2025161809A5 (enExample)
US11459588B2 (en) Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides
JP2022538789A5 (enExample)
CN107250148B (zh) 具有化学修饰的指导rna
JP2022540153A5 (enExample)
FI3802807T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi
JP7641952B2 (ja) 環状一本鎖ポリヌクレオチドを含む核酸送達ベクター
US20190241911A1 (en) Engineered guide rna and uses thereof
CA3220846A1 (en) Rna-guided cas(omega) nucleases and uses thereof in diagnostics and therapy
JP2025524456A (ja) B2m発現のエピジェネティック制御のための組成物および方法
WO2022187278A1 (en) Nucleic acid detection and analysis systems
WO2022212559A1 (en) Methods for targeted nucleic acid sequencing
CA3155960C (en) A nucleic acid delivery vector comprising a circular single stranded polynucleotide
JP2025525389A (ja) Ciita発現のエピジェネティック調節のための組成物及び方法
WO2025199534A1 (en) New r2 retrotransposons for gene writing
JP2025524455A (ja) Trac発現のエピジェネティック調節のための組成物及び方法
HK40102346A (en) Crispr hybrid dna/rna polynucleotides and methods of use
JP2025535776A (ja) 遺伝子を標的化、編集又は修飾するための組成物及び方法
CN121737085A (zh) 一种新型可编程核酸酶及其应用
HK1245839B (en) Crispr hybrid dna/rna polynucleotides and methods of use